In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites

Journal of Eukaryotic Microbiology

Volumn 49, Issue 3, 2002, Pages 201-208

  Cedillo Rivera, Roberto ^a   Chávez, Bibiana ^b   González Robles, Arturo ^b   Tapia, Amparo ^a   Yépez Mulia, Lilián ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

5 nitroimidazoles; Albendazole; Anaerobic protozoa; Carbamate benzimidazoles; Electron microscopy; Metronidazole; Nitrothiazolyl derivatives; Subculture method; Ultrastructure

Indexed keywords

PARASITE;

BLASTOCYSTIS; BLASTOCYSTIS HOMINIS; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; ENTAMOEBA; ENTAMOEBA HISTOLYTICA; GIARDIA; GIARDIA INTESTINALIS; PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 0036067661     PISSN: 10665234     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2002.tb00523.x     Document Type: Article

References (32)

1. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome
2. Action of metronidazole on Entamoeba histolytiea: An ultrastructural study
3. Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities
4. Nitazoxanide: Pharmacokinetics and metabolism in man
5. In vitro susceptibility of Giardia intestinalis to albendazole, mebendazole, and other chemotherapeutic agents
6. Giardia intestinalis: Ultrastructural study of the in vitro effect of benzimidazoles
7. Effects of albendazole on Entamoeba histolytica and Giardia intestinalis trophozoites
8. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms
9. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired inmmunodeficiency syndrome in tropical Africa
10. Activity of nitazoxanide alone and in combination with azithrocyn and rifabutin against Cryptosporidium parvum in cell culture
11. Metronidazole and drug resistance
12. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France
13. In vitro and in vivo activities of nitazoxanide against Clostridium difficile
14. Assay conditions and the demonstration of nitroimidazole resistance in Trichomonas foetus
15. Metabolism and metronidazole uptake in Trichomonas vaginalis isolated with different metronidazole susceptibilities
16. Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis, and Spironucleus muris using transmission electron microscopy
17. Determinación in vitro de la susceptibilidad a la nitazoxanida de cuatro aislados de Giardia duodenalis obtenidos de diferentes huéspedes
18. Efectividad y seguridad del mebendazol comparado con la nitazoxanida en el tratamiento de Giardia intestinalis en niños
19. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico
20. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections
21. Treatment of human fascioliasis with nitazoxanide
22. Treatment of diarrhea caused by Cryptosporidium parvum: A prospective randomized, double-bind, placebo-controlled study of nitazoxanide
23. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: A randomized, double-bind, placebo-controlled study of nitazoxanide
24. Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis
25. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica
26. Pharmacokinetics of nitazoxanide after single oral dose administration in six healthy volunteers
27. Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in β-tubulin
28. Drug targets and mechanism of resistance in the anaerobic protozoa
29. Blastocystis hominis: Neutral red supravital staining and its application to in vitro drug sensitivity testing
30. Albendazole
31. Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuoling toxin activity